RayBiotech's array system identifies key factors involved in dissemination of leprosy infection

RayBiotech, Inc. announced today that the application of its Mouse Cytokine Antibody Array has enabled the identification of key factors involved in the dissemination of leprosy infection in humans. This seminal research was conducted by Dr. Anura Rambukkana and colleagues at the Medical Research Council Center for Regenerative Medicine, University of Edinburgh and the Rockefeller University in New York. In this study, Dr. Rambukkana's team employed RayBiotech's Mouse Cytokine Antibody Array C-Series 1000 to test for the presence of biologically active proteins in media conditioned by adult Schwann cells infected with Mycobacterium leprae (the causative agent of leprosy). The application of this array allowed for the identification of key immunomodulatory factors secreted by these cells that promote bacteria-laden macrophage survival and migration, thus exacerbating M. leprae infection.

Commenting on the research, RayBiotech's President, Chief Operating Officer and Co-Founder, Rani Huang stated, "We congratulate Dr. Rambukkana's team on their findings regarding the biochemical factors aggravating leprosy infection and we are pleased to have provided multiplexing products and technologies for the efficient identification of these factors."

Dr. Rambukkana also commented, "RayBiotech's C-Series 1000 array was instrumental in identifying key soluble immune factors, not only cytokines and chemokines but also a whole range of secreted proteins, which provided compelling evidence that reprogrammed cells possess the capacity to recruit and modulate macrophages."


RayBiotech, Inc.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
SARS-CoV-2 ORF8 protein binds to dendritic cells and induces a hyper-inflammatory cytokine storm